Where is Pharmacodiabetes located?

Pharmacodiabetes is headquartered in Nepal.

Where does Pharmacodiabetes rank among its competitors?

Pharmacodiabetes ranks 115th amongst 106 active competitors, of which 11 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Kriya, which secured $484K in Nov, 2022.

Who are the top competitors of Pharmacodiabetes?

Pharmacodiabetes' top competitors include Beurer UK, i-SENS and Ascensia. Among them, Kriya secured the most recent funding round in November, 2022.

Pharmacodiabetes - 2026 Company Profile & Competitors

Pharmacodiabetes is an unfunded company based in Nepal. It operates as a Retailer of blood glucose meters and diabetes monitoring medical accessories. Pharmacodiabetes has not raised any funding yet. The company has 106 active competitors, including 11 funded and 18 that have exited. Its top competitors include companies like Beurer UK, i-SENS and Ascensia.

Company Details

Retailer of blood glucose meters and diabetes monitoring medical accessories. The business provides various medical tools including ketone meters, lancing devices, test strips, and data cables for personal health management. These devices assist individuals in tracking blood sugar levels and monitoring glucose control.

Key Metrics

Location

Nepal

Stage

Unfunded

Ranked

115^th among 155 competitors

Similar Companies

Beurer UK & 153 more

View Pharmacodiabetes' full profile

Pharmacodiabetes has not raised any funding rounds yet.

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Pharmacodiabetes include Beurer UK, i-SENS and Ascensia. Here is the list of Top 10 competitors of Pharmacodiabetes, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Beurer UK 1999, Ulm (Germany), Funding Raised	Developer of medical products and consumer devices	-	Peak	61/100
2nd	i-SENS 2000, Zhangjiagang (China), Public	Developer of blood glucose monitoring and clinical chemistry analyzers	-	IMM Investment, STIC Ventures & 8 others	60/100
3rd	Ascensia 2013, Basel (Switzerland), Unfunded	Developer of glucose monitoring systems and diabetes management software	-	-	59/100
4th	Telcare 2008, Bethesda (United States), Acquired	Cellular technology and social networking to tackle diabetes	$66.7M	Sequoia Capital, Qualcomm Ventures & 4 others	54/100
5th	Trividia Health 1985, Fort Lauderdale (United States), Acquired	Innovative diabetes solutions provider dedicated to healthier lives through affordable products	-	-	53/100
6th	LifeScan 1996, Chesterbrook (United States), Acquired	Innovating diabetes management solutions, empowering healthier lives through technology and partnerships	-	Sutter Hill Ventures, ABS Ventures	50/100
7th	Biosense 2008, Mumbai (India), Acquired	Developer of diagnostic devices for multiple diseases	$3.94M	Insitor Partners, Menterra Venture Advisors ... & 29 others	50/100
8th	Smart Meter 2009, Tampa (United States), Unfunded	Cloud-based remote patient monitoring solutions for healthcare providers	-	-	49/100
9th	Sinocare 2002, Changsha (China), Funding Raised	Develops and markets POC devices	-	Broad Vision Funds, Lotus Lake Capital Management	45/100
10th	Kriya 2006, Chennai (India), Series A	Developer of health care products for diagnosis and treatment	$4.5M	S A S Fininvest, MG INDUSTRIAL HOLDINGS & 5 others	45/100
115th	Pharmacodiabetes Nepal, Unfunded	Retailer of blood glucose meters and diabetes monitoring medical accessories	-	-	16/100